CONFERENCE UPDATE: AAAAI 2023
Demonstrated efficacy of lanadelumab at fixed and modified dosing regimens in patients aged 2 to <12 years with HAE: The SPRING study
30 Mar 2023
Related Articles
CONFERENCE UPDATE: AAAAI 2023
Demonstrated efficacy of lanadelumab at fixed and modified dosing regimens in patients aged 2 to <12 years with HAE: The SPRING study